Segments From this episode
Swiss drug maker Roche is acquiring U.S. biotech giant Genentech in a $47 billion deal. Sam Eaton reports on the latest example of a pharmaceutical company buying out a competitor to boost its product line.
Despite its reputation as the love drug, ecstasy has a violent back story. Host Kai Ryssdal talks with "Chemical Cowboys" author Lisa Sweetingham about the investigations that ended an ecstasy empire.
Marketplace for Thursday, March, 12, 2009